Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| STXS | Stereotaxis, Inc. | 2026-10-08 08:44:51 | 1.09 | -0.04 | -3.52 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STXS | 0001289340 | Stereotaxis, Inc. | US85916J4094 | 549300KPNOKI02O2ZP21 | 943120386 | NYSE | 3845 | Electromedical & Electrotherapeutic Apparatus | 1231 | DE | 710 N TUCKER BLVD | ST.LOUIS | MO | 63101 | UNITED STATES | US | 314-678-6100 | 710 N TUCKER BLVD, ST.LOUIS, MO, 63101 | 710 N TUCKER BLVD, ST.LOUIS, MO, 63101 | — | — | — | David L. Fischel | — | https://www.stereotaxis.com | 150,300,000 | 97,938,091 | 100,202,178 | Stereotaxis Inc. is an American publicly traded medical technology company based in St. Louis, Missouri, that makes robotic systems used by physicians to perform minimally-invasive endovascular procedures, including electrophysiology studies and cardiac catheter ablation procedures. | 2026-10-01 22:00:15 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 150,300,000 | 26,400,000 | 21.3075 | 97,248,936 | 11,269,274 | 13.1069 |
| 2024 | 123,900,000 | 23,000,000 | 22.7948 | 85,979,662 | 3,850,900 | 4.6889 |
| 2023 | 100,900,000 | -9,800,000 | -8.8528 | 82,128,762 | 7,083,278 | 9.4386 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| David L. Fischel | Chief Executive Officer | 2025 | 60,000 | — | 0 | 0 | 4,390 | 64,390 |
| Kimberly R. Peery | Chief Financial Officer | 2025 | 232,500 | — | 0 | 20,000 | 18,211 | 326,111 |
| Kimberly R. Peery | Chief Financial Officer | 2024 | 226,750 | — | 0 | 20,000 | 8,895 | 340,165 |
| David L. Fischel | Chief Executive Officer | 2024 | 60,000 | — | 0 | 0 | 2,195 | 62,195 |
| David L. Fischel | Chief Executive Officer | 2023 | 60,000 | — | 0 | 0 | 2,195 | 62,195 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 131 |
| 2024 | 139 |
| 2023 | 122 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 32,377,000 | 26,918,000 | 26,771,000 |
| Cost Of Revenue | 15,306,000 | 12,324,000 | 11,911,000 |
| Gross Profit | 17,071,000 | 14,594,000 | 14,860,000 |
| Research And Development Expenses | 9,383,000 | 9,760,000 | 10,273,000 |
| General And Administrative Expenses | 17,849,000 | 17,201,000 | 14,050,000 |
| Operating Expenses | 39,183,000 | 39,333,000 | 36,699,000 |
| Operating Income | -22,112,000 | -24,739,000 | -21,839,000 |
| Net Income | -21,643,000 | -24,045,000 | -20,713,000 |
| Earnings Per Share Basic | -0.25 | -0.3 | -0.27 |
| Earnings Per Share Diluted | -0.25 | -0.3 | -0.27 |
| Weighted Average Shares Outstanding Basic | 90,957,313 | 85,183,306 | 80,702,358 |
| Weighted Average Shares Outstanding Diluted | 90,957,313 | 85,183,306 | 80,702,358 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 13,421,000 | 12,217,000 | 19,818,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 5,847,000 | 3,824,000 | 3,822,000 |
| Inventories | 9,567,000 | 8,331,000 | 8,426,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 698,000 | 1,848,000 | 676,000 |
| Total Assets Current | 33,849,000 | 26,439,000 | 33,267,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 3,019,000 | 3,573,000 | 3,304,000 |
| Other Assets Non Current | — | — | — |
| Total Assets Non Current | 18,402,000 | 20,285,000 | 8,642,000 |
| Total Assets | 52,251,000 | 46,724,000 | 41,909,000 |
| Accounts Payable | 4,768,000 | 5,668,000 | 3,190,000 |
| Deferred Revenue | 5,675,000 | 6,804,000 | 6,657,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 2,065,000 | 2,922,000 | 2,972,000 |
| Total Liabilities Current | 22,360,000 | 21,602,000 | 13,247,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 1,097,000 | 64,000 | 43,000 |
| Total Liabilities Non Current | 11,170,000 | 13,690,000 | 6,742,000 |
| Total Liabilities | 33,530,000 | 35,292,000 | 19,989,000 |
| Common Stock | 95,000 | 85,000 | 81,000 |
| Retained Earnings | -583,368,000 | -561,725,000 | -537,680,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 13,481,000 | 6,080,000 | 16,343,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 626,000 | 382,000 | 595,000 |
| Share Based Compensation Expense | 9,852,000 | 10,262,000 | 10,623,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 2,023,000 | -691,000 | -1,268,000 |
| Change In Inventories | 1,236,000 | -677,000 | 550,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 170,000 | -29,000 | -71,000 |
| Change In Accounts Payable | -880,000 | 758,000 | 218,000 |
| Change In Other Liabilities | -13,000 | 21,000 | -8,000 |
| Cash From Operating Activities | -13,685,000 | -8,497,000 | -9,139,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 93,000 | 34,000 | 366,000 |
| Acquisition Of Business | — | 451 | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -93,000 | 74,000 | 19,765,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 15,656,000 | 297,000 | 81,000 |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 14,763,000 | 297,000 | 81,000 |
| Change In Cash | 985,000 | -8,126,000 | 10,707,000 |
| Cash At End Of Period | 13,421,000 | 12,217,000 | 19,818,000 |
| Income Taxes Paid | — | — | — |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.25 | -0.3 | -0.27 |
| Price To Earnings Ratio | -9.2 | -7.6 | -6.4815 |
| Earnings Growth Rate | -16.6667 | 11.1111 | 3.8462 |
| Price Earnings To Growth Ratio | 0.552 | -0.684 | -1.6852 |
| Book Value Per Share | 0.2058 | 0.1342 | 0.2716 |
| Price To Book Ratio | 11.1747 | 16.989 | 6.4429 |
| Ebitda | -20,550,000 | -22,969,000 | -19,022,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 72,000 | 651,000 | 68,000 |
| Free Cash Flow | -13,757,000 | -9,148,000 | -9,207,000 |
| Return On Equity | -1.6054 | -3.9548 | -1.2674 |
| One Year Beta | 1.3345 | 0.9283 | 0.4367 |
| Three Year Beta | 1.0148 | 1.1111 | 1.1206 |
| Five Year Beta | 1.1506 | 0.962 | 0.9814 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Menawat Arun Swarup | Director | 2026-07-01 | 43,103 | A | 1,035,560 |
| Fischel Nathan | Director, 10% owner | 2026-07-01 | 43,103 | A | 720,775 |
| Curet Myriam | Director | 2026-07-01 | 43,103 | A | 435,161 |
| Levin Ross B | Director | 2026-07-01 | 43,103 | A | 621,248 |
| Benfer David | Director | 2026-07-01 | 43,103 | A | 558,975 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Investors Research Corp | 2026-09-30 | 22,079 | 17,950 | 1.23 |
| Hickory Point Bank & Trust | 2026-09-30 | 1,845 | 1,500 | 1.23 |
| ENVESTNET ASSET MANAGEMENT INC | 2026-06-30 | 157,514 | 91,578 | 1.72 |
| STATE STREET CORP | 2026-06-30 | 1,576,862 | 916,780 | 1.72 |
| Arbiter Partners Capital Management LLC | 2026-06-30 | 4,960,232 | 2,883,856 | 1.72 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| VICTORY PORTFOLIOS III | 2026-07-31 | Victory Extended Market Index Fund | USMIX | 9,499 | 11,968.74 | 0.0015 |
| Global X Funds | 2026-07-31 | Global X Russell 2000 ETF | RSSL | 32,568 | 41,035.68 | 0.0028 |
| PRINCIPAL FUNDS, INC. | 2026-07-31 | R-6 | PCSMX | 4,266 | 5,375.16 | 0.0002 |
| PRINCIPAL FUNDS, INC. | 2026-07-31 | Class J | PSIJX | 4,266 | 5,375.16 | 0.0002 |
| PRINCIPAL FUNDS, INC. | 2026-07-31 | Institutional Class | PGRTX | 4,266 | 5,375.16 | 0.0002 |